Major milestones achieved with the success of Soft Tissue Sarcoma phase III clinical trial with first-in-class NBTXR3 product Overall expenses according to pla...

Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK Cambridge, Mass., USA, September 05, 201...

The European Commission (EC) has granted approval for Novartis’ Kymriah to treat patients with B-cell acute lymphoblastic leukaemia (ALL) and diffuse large B-cell lym...

An early clinical trial conducted by UK researchers has demonstrated positive profile for the use of vistusertib and paclitaxel combination to treat ovarian and lung...

The full integration of Ascom Unite Connect for clinical systems with Dräger Infinity patient monitoring systems will deliver mobile alert message notifications, cus...

Munich, Germany, 26 August 2018 ­- Ozempic® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack...

Pfizer and Spark Therapeutics announced that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evaluate the efficacy and safety of c...

 Boehringer Ingelheim and Eli Lilly and Company reported that the CARMELINA cardiovascular outcome trial evaluating their diabetes drug Tradjenta met its primary ...

New research published in the August edition of the Journal of the American College of Cardiology's Heart Failure issue found significant correlations between blood l...